CalciMedica, Inc. - SIC # 2830 -

Ticker Exchange SIC # Website Latest Ticker
CALC Nasdaq 2830 calcimedica.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for CalciMedica, Inc.

CalciMedica Reports Third Quarter 2025 Financial Results and Provides Clinical & Corporate Updates - Nov 12th, 2025 5:01 am
CalciMedica Announces Publication in JCI Insight of Preclinical Data Supporting CRAC Channel Inhibitor as a Potential Therapy for Pulmonary Arterial Hypertension - Nov 12th, 2025 5:00 am
CalciMedica Presents Data from Preclinical Study of Auxora™ in an Animal Model of AKI at ASN Kidney Week 2025 - Nov 10th, 2025 5:00 am
CalciMedica and Telperian Announce Collaboration to Integrate Innovative Artificial Intelligence Engine to Analysis of Clinical Trials of Auxora™ - Oct 14th, 2025 5:00 am
CalciMedica to Participate in the H.C. Wainwright 27th Annual Global Investment Conference - Sep 2nd, 2025 5:00 am
CalciMedica Reports Second Quarter 2025 Financial Results and Provides Clinical & Corporate Updates - Aug 12th, 2025 5:00 am
CalciMedica to Participate in the H.C. Wainwright 4th Annual Kidney Virtual Conference - Jul 8th, 2025 5:00 am
CalciMedica Announces Publication in the American Journal of Nephrology Discussing Design and Rationale of Phase 2 KOURAGE Trial of Auxora™ in AKI with Respiratory Failure - Jun 25th, 2025 5:00 am
CalciMedica Insiders Added US$1.05m Of Stock To Their Holdings - Jun 13th, 2025 5:51 am
CalciMedica Announces Upcoming Symposium at the 43rd Vicenza Course AKI-CRRT-EBPT and Critical Care Nephrology Meeting - Jun 12th, 2025 5:00 am
CalciMedica Reports First Quarter 2025 Financial Results and Provides Clinical & Corporate Updates - May 14th, 2025 5:00 am
CalciMedica Announces Presentations at Upcoming Medical Meetings - Apr 17th, 2025 5:00 am
CalciMedica to Participate in the Jones Healthcare and Technology Innovation Conference - Apr 1st, 2025 5:00 am
CalciMedica Reports 2024 Financial Results and Provides Clinical & Corporate Updates - Mar 27th, 2025 5:00 am
CalciMedica Secures Credit Facility for Up to $32.5 Million - Mar 5th, 2025 5:00 am
CalciMedica Presents AKI Data from a Post-Hoc Analysis of the Phase 2 CARDEA trial of Auxora™ in Severe COVID-19 Pneumonia at the 30th International AKI & CRRT Conference - Mar 4th, 2025 5:00 am
CalciMedica Announces Upcoming Plenary Presentation at the 30th International AKI & CRRT Conference - Feb 19th, 2025 5:00 am
CalciMedica to Participate in the Oppenheimer 35th Annual Healthcare Life Sciences Conference - Feb 3rd, 2025 2:05 pm
CalciMedica Announces Appointment of Dr. Alan Glicklich to Board of Directors - Jan 14th, 2025 5:00 am